Health policy experts say one flaw with the administration’s plan is the lack of any serious follow through.
Credit: Reuters
President Donald Trump in May said that drugmakers would soon announce “massive” price cuts, and his administration rolled out a plan to bring down the cost of medicines. But the companies don’t appear to have gotten that message.
Bayer raised the price of two cancer drugs by hundreds of dollars in May and Novartis followed by boosting four pricey treatments in June. Pfizer, one of the largest U.S. pharmaceutical companies, announced increases on more than 41 products this week. They weren’t alone.
A Wells Fargo report found 104 price increases in June and the first two days of July, with an average jump of 31.5 percent and a median increase of 9.4 percent. That followed 48 increases in May. The list price hikes don’t factor in discounts that companies may provide to some insurance companies and patients.
The across-the-board increases cast doubt on whether Trump and Health and Human Services Secretary Alex Azar can […]
I’m up far too late for my age. hahaha I know a former VP for J&J from Montreal, Canada. He candidly told me that their *normal* profit level for pharmaceuticals was 3000% Accept what you want, but, today after what Stephan has published, believe it or else. Have a great 4th my American friends.